Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases
- 6 March 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (11) , 4246-4251
- https://doi.org/10.1073/pnas.0511256103
Abstract
Misfolded proteins accumulate in many neurodegenerative diseases, including huntingtin in Huntington’s disease and α-synuclein in Parkinson’s disease. The disease-causing proteins can take various conformations and are prone to aggregate and form larger cytoplasmic or nuclear inclusions. One approach to the development of therapeutic intervention for these diseases has been to identify chemical compounds that reduce the size or number of inclusions. We have, however, identified a compound that promotes inclusion formation in cellular models of both Huntington’s disease and Parkinson’s disease. Of particular interest, this compound prevents huntingtin-mediated proteasome dysfunction and reduces α-synuclein-mediated toxicity. These results demonstrate that compounds that increase inclusion formation may actually lessen cellular pathology in both Huntington’s and Parkinson’s diseases, suggesting a therapeutic approach for neurodegenerative diseases caused by protein misfolding.Keywords
This publication has 23 references indexed in Scilit:
- A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in DrosophilaProceedings of the National Academy of Sciences, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing proteinHuman Molecular Genetics, 2003
- TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregationJournal of Neurochemistry, 2002
- Aggregate formation inhibits proteasomal degradation of polyglutamine proteinsHuman Molecular Genetics, 2002
- The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of ConstructionPhysiological Reviews, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Folding of Newly Translated Proteins In Vivo: The Role of Molecular ChaperonesAnnual Review of Biochemistry, 2001
- Impairment of the Ubiquitin-Proteasome System by Protein AggregationScience, 2001
- Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c releaseHuman Molecular Genetics, 2001